Axel Mark Inc. (3624.T)
JPY 100.0
(-3.85%)
JPY 100.0
(-3.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -172.86 Million | 93.53 Million | -13.59 Million | -660.06 Million | -498 Thousand |
| Net Income | -101.47 Million | -95.85 Million | 79.6 Million | -822.65 Million | -1.2 Million |
| Depreciation & Amortization | 7.25 Million | 4.19 Million | 5.02 Million | 31.82 Million | 140 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -53.64 Million | 72.25 Million | -20.61 Million | 79.98 Million | 83 Thousand |
| Other non-cash items | -23 Million | 9.4 Million | 13.28 Million | -39.97 Million | 479 Thousand |
| Investing Cash Flow | -162.2 Million | 7.46 Million | 89.12 Million | -71.2 Million | -274 Thousand |
| Investments in PPE | -102.46 Million | - | - | - | -146.45 Million |
| Acquisitions | - | - | 1.82 Million | 20 Million | - |
| Investment purchases | - | - | -109.28 Million | -385 Million | -165 Million |
| Sales/Maturities of investments | - | 4.31 Million | 150 Million | 295 Million | 40 Million |
| Other Investing Activities | -65.14 Million | 3.15 Million | 46.57 Million | -1.2 Million | -3.11 Million |
| Financing Cash Flow | 1.01 Million | 500 Thousand | 812.11 Million | -126.59 Million | 1.14 Million |
| Debt repayment | - | - | -150 Million | -300 Million | -164.75 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 405.33 Million | 173.4 Million | 307.85 Million |
| Other Financing Activities | 1.01 Million | 500 Thousand | 556.77 Million | 1000.00 | 1.31 Million |
| Accounts receivables | -5.6 Million | 128.02 Million | -98.52 Million | 121 Thousand | 40 Thousand |
| Accounts payables | -12.96 Million | -70.65 Million | 70.76 Million | -56.17 Million | 37.03 Million |
| Inventory | -30.99 Million | 1.02 Million | -4.4 Million | 5.13 Million | -363 Thousand |
| Other working capital | -26.4 Million | 15.59 Million | 25.16 Million | -33 Thousand | 43 Thousand |
| Cash at beginning of period | 1.24 Billion | 1.13 Billion | 250.95 Million | 1.11 Billion | 740.87 Million |
| Cash at end of period | 906.03 Million | 1.24 Billion | 1.13 Billion | 256.74 Million | 375 Thousand |
| Capital Expenditure | -102.46 Million | - | - | - | -146.45 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -334.06 Million | 101.49 Million | 887.65 Million | -857.86 Million | -740.5 Million |
| Free Cash Flow | -275.32 Million | 93.53 Million | -13.59 Million | -660.06 Million | -146.95 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | -101.47 Million | -95.85 Million | 79.6 Million | -822.65 Million | -1.2 Million |
| Depreciation & Amortization | 7.25 Million | 4.19 Million | 5.02 Million | 31.82 Million | 140 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -53.64 Million | 72.25 Million | -20.61 Million | 79.98 Million | 83 Thousand |
| Other non-cash items | -23 Million | 9.4 Million | 13.28 Million | -39.97 Million | 479 Thousand |
| Investing Cash Flow | -162.2 Million | 7.46 Million | 89.12 Million | -71.2 Million | -274 Thousand |
| Investments in PPE | -102.46 Million | - | - | - | -146.45 Million |
| Acquisitions | - | - | 1.82 Million | 20 Million | - |
| Investment purchases | - | - | -109.28 Million | -385 Million | -165 Million |
| Sales/Maturities of investments | - | 4.31 Million | 150 Million | 295 Million | 40 Million |
| Other Investing Activities | -65.14 Million | 3.15 Million | 46.57 Million | -1.2 Million | -3.11 Million |
| Financing Cash Flow | 1.01 Million | 500 Thousand | 812.11 Million | -126.59 Million | 1.14 Million |
| Debt repayment | - | - | -150 Million | -300 Million | -164.75 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 405.33 Million | 173.4 Million | 307.85 Million |
| Other Financing Activities | 1.01 Million | 500 Thousand | 556.77 Million | 1000.00 | 1.31 Million |
| Accounts receivables | -5.6 Million | 128.02 Million | -98.52 Million | 121 Thousand | 40 Thousand |
| Accounts payables | -12.96 Million | -70.65 Million | 70.76 Million | -56.17 Million | 37.03 Million |
| Inventory | -30.99 Million | 1.02 Million | -4.4 Million | 5.13 Million | -363 Thousand |
| Other working capital | -26.4 Million | 15.59 Million | 25.16 Million | -33 Thousand | 43 Thousand |
| Cash at beginning of period | 1.24 Billion | 1.13 Billion | 250.95 Million | 1.11 Billion | 740.87 Million |
| Cash at end of period | 906.03 Million | 1.24 Billion | 1.13 Billion | 256.74 Million | 375 Thousand |
| Capital Expenditure | -102.46 Million | - | - | - | -146.45 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -334.06 Million | 101.49 Million | 887.65 Million | -857.86 Million | -740.5 Million |
| Free Cash Flow | -275.32 Million | 93.53 Million | -13.59 Million | -660.06 Million | -146.95 Million |
MEDICO
FPH
9034
NESN
RBSFY
MPP